Lamprou Charalampos

Lamprou Charalampos Internist

Education & Academic Qualifications

  • September 1990 – June 1991 Preliminary course for foreign students, Faculty of Medicine, Ludwig-Maximilians University of Munich, Germany
  • October1991 – November 1995 Faculty of Medicine, Ludwig-Maximilians University of Munich, Germany
  • November 1995 – May 2000 Faculty of Medicine, National and Kapodistrian University of Athens, Greece
  • December 2009 Post-graduate qualification in Internal Medicine

 

Work Experience

  • December 2014 – May 2016 On call doctor, Hygeia Hospital

  • October 2014 – present Attending physician, Hygeia Hospital

  • January 2010 – present Private Practice, Internal Medicine, Nea Ionia, Attiki. Authorized with the Greek National Health Service and Private Medical Insurance Companies

  • January 2011 – October 2014 Assistant, 3rd Oncology department, Hygeia Hospital

  • August 2010 – December 2010 Physician, Department of Internal Medicine, Sotir Clinic

  • September 2009 – October 2014 On call doctor, Oncology department, Hygeia Hospital

  • November 2002 – August 2008 Medical Doctor for football and basketball matches

  • December 2004 – June 2009 Registrar, Department of Internal Medicine, KAT General Hospital.

  • During this time also served on the National committee of Exams for the Ministry of Education (June 2007, 2008)

  • November 2002 – November 2004 Medical Doctor (and on call doctor), Psychiatric Clinic of “Agios Gerasimos”, Acharnon

  • August 2002 – November 2002 On call doctor for the Pathological Clinic “Agios Georgios”, Kipselis and Psychiatric Clinic “Agios Gerasimos”, Acharnon

  • August 2001 – August 2002 Internship, Politika Regional Clinic, Evias (on call doctor Psachnon Health Center)

  • March 2001 – June 2001 Obligatory Rural Service, Chalkida Hospital

 

Clinical & Research Interest

  • Participation in pharmaceutical protocols in the treatment of Hepatitis C

  • Participation in pharmaceutical protocols in the treatment of asthma and COPD (Chronic Obstructive Pulmonary Disease)

  • Participation in pharmaceutical protocols in the treatment of hypertension